A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19.
Liu WD, Feng PH, Cheng CY, Chou CL, Lee CH, Lu MC, Liu PY, Lee MH, Liao CH, Chen MC, Chen CP, Hsu SF, Tzeng YT, Lin YC, Ou TY, Qin A, Tsai CY, Shih WJ, Lee KY, Sheng WH.
Liu WD, et al. Among authors: sheng wh.
Infect Dis Ther. 2024 Jul;13(7):1575-1588. doi: 10.1007/s40121-024-00992-5. Epub 2024 May 21.
Infect Dis Ther. 2024.
PMID: 38771550
Free PMC article.